Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)
Saarland University · Leipzig University · +18 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,133
total citations
- FWCI
- 46.13
- Percentile
- 100%
- References
- 19
Citations per year
Authors
26Topics & keywords
Topics
Keywords
- CHOP
- Medicine
- Rituximab
- Vincristine
- Internal medicine
- Clinical endpoint
- Lymphoma
- Gastroenterology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.